was withdrawn from circulation - traducción al italiano
DICLIB.COM
Herramientas lingüísticas IA
Ingrese una palabra o frase en cualquier idioma 👆
Idioma:     

Traducción y análisis de palabras por inteligencia artificial

En esta página puede obtener un análisis detallado de una palabra o frase, producido utilizando la mejor tecnología de inteligencia artificial hasta la fecha:

  • cómo se usa la palabra
  • frecuencia de uso
  • se utiliza con más frecuencia en el habla oral o escrita
  • opciones de traducción
  • ejemplos de uso (varias frases con traducción)
  • etimología

was withdrawn from circulation - traducción al italiano

WIKIMEDIA LIST ARTICLE
Withdrawn drug; List of medication withdrawn from the market; List of medications withdrawn for safety

was withdrawn from circulation      
fu messo fuori circolazione
currency in circulation         
CONTINUED USE OF CURRENCY
Money circulation; Circulation (currency)
moneta in circolo
atmospheric circulation         
  • The [[ITCZ]]'s band of clouds over the [[Eastern Pacific]] and the [[Americas]] as seen from space
  • Long-term mean [[precipitation]] by month
LARGE-SCALE MOVEMENT OF AIR, A MEANS BY WHICH THERMAL ENERGY IS DISTRIBUTED ON EARTH'S SURFACE
Ferrel cell; Global winds; Polar cells; Atmosphere circulation; 3 Cell Model; Three Cell Model; Ferrell cell; Three-cell model; Ferrel Cell; Ferrell cells; Global air circulation; Circulation (meteorology)
circolazione atmosferica

Definición

circulation
n.
distribution
1) to put into circulation (to put more money into circulation)
2) to withdraw from circulation (to withdraw old banknotes from circulation)
3) enormous, large, wide; general; limited, small; national, nationwide circulation (this magazine has attained a wide circulation)
4) in circulation (this money is no longer in circulation)
movement
5) blood circulation; or: circulation of the blood
6) good, healthy; poor circulation

Wikipedia

List of withdrawn drugs

Drugs or medicines may be withdrawn from commercial markets because of risks to patients, but also because of commercial reasons (e.g. lack of demand and relatively high production costs). Where risks or harms is the reason for withdrawal, this will usually have been prompted by unexpected adverse effects that were not detected during Phase III clinical trials, i.e. they were only made apparent from postmarketing surveillance data collected from the wider community over longer periods of time.

This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market. Some drugs in this list (e.g. LSD) were never approved for marketing in the US or Europe.